首页 | 本学科首页   官方微博 | 高级检索  
相似文献
 共查询到20条相似文献,搜索用时 15 毫秒
1.
《Tetrahedron》1986,42(23):6399-6404
Three major metabolites of felbamate, namely 2-(4-hydroxyphyenyl)-1, 3-propanediol dicarbamate. [4], 2-hydroxy-2-phenyl-1,3-propanediol dicarbamat [12], and 2-phenyl-1,3-propanediol monocarbamate [17] were prepared. The first metabolite, 4, was synthesised from p-methoxy-phenylacetic acid [1] via five steps involving carboxylation, reduction, phosgenation, demethylation, and carbonation. The second one, 12, was prepared from 2-phenyl-1,3-propanediol [7] by the following five steps; phosgenation, halogenation, carbonation, dehalogenation, and ammonolysis. The synthesis of the third metabolite, 17, started with 7, via the following five steps: methylation, phosgenation, carbonation, and demethylation.  相似文献   

2.
3.
单自兴  卢国坚 《有机化学》2004,24(3):325-327
报告多官能团化合物苏 (1S ,2S) 2 (N ,N 二甲胺基 ) 1 (对硝基苯基 ) 1,3 丙二醇与聚合物支载条件下的溴试剂发生的一种新的选择性N 甲基氧化为N 甲酰基的反应 .在Na2 HPO4存在下 ,苏 (1S ,2S) 2 (N ,N 二甲胺基 ) 1 (对硝基苯基 ) 1,3 丙二醇于水 CCl4体系中被 717阴离子交换树脂支载的溴在 60℃氧化 2 4h给出 5 1%收率的苏 (1S ,2S) 2 (N 甲基 N 甲酰胺基 ) 1 (对硝基苯基 ) 1,3 丙二醇 .这种选择性N 甲基氧化为N 甲酰基的反应在 2 氨基 1,3 丙二醇衍生物化学中是第一次观察到 .  相似文献   

4.
IntroductionChloramphenicol,which was isolated fromStreptomyces venezuelae in 1 947[1] ,is used as abroad- spectrum antibiotic possessing activityagainst many Gram- negative and Gram- positivemicroorganisms. (± ) - 2 - Acetamido- 3 - hydroxy- 1 -(4- nitrophenyl) - 1 - propanone[(± ) - 1 ]is one of theintermediates of producing chloramphenicol.Petrow et al.[2 ] reported some transformations of(± ) - 1 in hydrolysis reactions. However,thereaction products were complicated under multiplehydr…  相似文献   

5.
(1S,3S)-1,3-二苯基-1,3-丙二胺的合成   总被引:1,自引:1,他引:0  
以二氯甲烷作溶剂,N-Boc保护的二氢吡唑在六甲基磷酰胺存在下与苯基格氏试剂反应,比较大量地制备了对应的四氢吡唑(4);再由4合成消旋的1,3-二苯基-1,3-丙二胺(1,总收率35%);1经L-二苯甲酰酒石酸盐拆分制得光学纯的(1S,3S)-1,3-二苯基-1,3-丙二胺,其结构经1HNMR确证。  相似文献   

6.
7.
The title compound, C17H20O5, (I), is structurally related to naturally occurring 1-aryl-2-aryloxy-1-propanols. Such compounds are of interest as lignin models, and neolignans of this type have been detected in a large number of plants. In the crystal structure of (I), the molecules adopt a conformation in which the aryl groups are far apart from each other. The O(aryloxy)—C—C—C(aryl) torsion angle is 177.76 (14)°. The conformation is compared with those of other compounds (neolignans and lignin model compounds) of the 1-aryl-2-aryloxy-1-propanol type (including some acetate derivatives). The comparison shows that in all the examined compounds the above-mentioned torsion angle is close to 180°, and the distance between the centers of the aromatic rings approaches the maximum achievable in most of the compounds. The hydrogen-bonding pattern of (I) is discussed in terms of graph-set theory.  相似文献   

8.
Benzopyran compounds possess diverse pharmacological properties such as β-blockade, anticonvulsant and antimicrobial.[1,2] Our interest has been focused on the synthesis of 1-[6-Fluoro-2S]-3H,4H-dihydro-2H-2-chromenyl]-(1R)-1,2-ethanediol (6) and 1-[6-fluoro-(2R)-3H,4H-dihydro-2H-2-chromenyl]-(1R)-1,2-ethanediol (7) which are particularly convenient precursor to (S,R,R,R)-NE (8). 8 containing four asymmetrical carbon atoms was reported to be the most active isomer.[3] Chandrasekhar[4] has reported on the synthesis of 8. The key step to synthesize this compound is to obtain the chiral chromanone 6 and 7. 6 was accomplished in 8 steps by the Clasien rearrangement and a one-pot Sharpless asymmetric epoxidation, but the compound 7 was accomplished in 10 steps. Johannes[5] used Zr-catalytic kinetic resolution of allylic ethers and Mo-catalyzed chromene formation to synthesize 8 in 14 steps. However both of the methods request many synthetic steps and expensive reagents.  相似文献   

9.
10.
11.
《Tetrahedron: Asymmetry》1999,10(5):991-1000
A range of novel C2-symmetric dioxygen and dinitrogen ligands can readily be obtained through the interconversion of the parent 1,3-diphenyl-1,3-propanediol enantiomers which are, in turn, accessed in good yields via a Sharpless asymmetric epoxidative resolution.  相似文献   

12.
13.
14.
Reactions of 2-hydroxy-5-(1-admantyl)benzene-1,3-dicarbaldehyde with ethane-1,2-diamine, transcyclohexane-1,2-diamine, and N-(2-aminoethyl)ethane-1,2-diamine were studied in strongly dilute solution and under conditions of template synthesis in the presence of H3BO3. The effects of reaction conditions and initial diamine structure on the cyclocondensation process were determined. Selective [3 + 3]-cyclocondensation of 2-hydroxy-5-(1-admantyl)benzene-1,3-dicarbaldehyde with trans-cyclohexane-1,2-diamine and [2 + 2]-cyclization with N-(2-aminoethyl)ethane-1,2-diamine were performed in chloroform in the presence of H3BO3. The first representative of adamantylcalixsalens was synthesized.  相似文献   

15.
A series of isomeric 2-oxazolidinones has been synthesized from (1S, 2S)-2-amino-1-(4-nitrophenyl)-1,3-propanediol. __________ Translated from Khimiya Geterotsiklicheskikh Soedinenii, No. 4, pp. 579–584, April, 2006.  相似文献   

16.
17.
The condensation of 4-hydroxy-3,5-diphenyl-2-phenyliminothiazolidine with 5-fluoro-4-morpholino- and 5-fluoro-4-(4-methylpiperazino)-1,2-phenylenediamines leads to region-isomeric thiazolo[3,4-a]quinoxalines differing in substituents in positions 7 and 8 of the benzene ring. From the ratio of isomers formed it follows that the mesomeric effect of a fluorine atom in 1,2-phenylenediamines is comparable with the influence of an aminosubstituent.  相似文献   

18.
19.
20.
Polarity of 2-(1-methylbenzimidazol-2-yl)-1-phenyl- and -1,2-diphenyl-1-nitroethenes was determined and their structure was studied using electronic and 1H, 13C NMR spectroscopy, dipole moments measuring, XRD analysis, and quantum-chemical calculations. It was shown that the 2-(1-methylbenzimidazol-2-yl)-1-nitro-1-phenylethene has Z-configuration both in crystal and solution. The nitro group and benzimidazole substituent in its molecule are removed from the plane of the double bond. For 1,2-diphenyl-1-nitroethene E-structure is typical.  相似文献   

设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号